EN
EN
About TCRCure
Research and Development
Product and Cinical trial
News and Media
We strive to make patients-driven cellular immunotherapy innovation,
to transform cancer into a manageable condition — and ultimately cure it.
 
HomeProduct and Cinical trialPipelines
Pipelines
Pipelines
China Global U.S.A
Pipeline Details
Pipelines
Indication
Discovery
Pre-clinical
Clinical PhaseⅠ
Clinical PhaseⅡ
ALPP ASPIRE-T
Gynecological, Lung
 
I301 ASPIRE-T
Brain cancer
 
N201 TCR-T
Sarcoma
 
L200 TCR-T
EBV-associated Cancers
 
H101 Neoantigen vaccine
DMG
 
DLL3 ASPIRE-T
ASPIRE-T
 
GPC3 ASPIRE-T
Liver, Lung
 
BCMA ASPIRE-T
MM
 

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer